Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
1.560
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
1.560
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Adial Pharmaceuticals Employees
Adial Pharmaceuticals had 5 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,595,434
Market Cap
2.24M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 36 |
| Scinai Immunotherapeutics | 31 |
| Calidi Biotherapeutics | 29 |
| BiomX | 20 |
| Silexion Therapeutics | 14 |
| Biodexa Pharmaceuticals | 11 |
| Decoy Therapeutics | 11 |
| CNS Pharmaceuticals | 5 |
ADIL News
- 1 day ago - Adial Pharmaceuticals Submits Application to FDA Commissioner's National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program - GlobeNewsWire
- 6 days ago - Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial - GlobeNewsWire
- 2 months ago - Adial Pharmaceuticals Regains Full Compliance with Nasdaq Listing Requirement - GlobeNewsWire
- 2 months ago - Adial Pharmaceuticals Highlights FDA Policy Direction That May Reduce Pivotal Trial Burden from Two Studies to One - GlobeNewsWire
- 2 months ago - Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04 - GlobeNewsWire
- 2 months ago - Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price Requirement - GlobeNewsWire
- 6 months ago - Adial Pharmaceuticals CEO was a Featured Guest on The Big Biz Show - GlobeNewsWire
- 7 months ago - Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution - GlobeNewsWire